AdvanSix (NYSE: ASIX) reported Q4 2025 sales of USD 359.95 million, up about 9% year over year, and a net loss of USD 2.79 million (diluted EPS: -USD 0.10). Adjusted EBITDA was USD 24.76 million (Adjusted EBITDA margin: 6.9%) and free cash flow was USD 36.13 million. For FY 2025, AdvanSix posted sales of USD 1.52 billion, net income of USD 49.29 million (diluted EPS: USD 1.80), Adjusted EBITDA of USD 156.8 million (Adjusted EBITDA margin: 10.3%), and free cash flow of USD 6.42 million. FY 2025 sales by product line were Plant Nutrients USD 563.69 million (37% of total), Chemical Intermediates USD 377.5 million (25%), Nylon USD 309.68 million (20%), and Caprolactam USD 271.37 million (18%). Management said FY 2025 results reflected cyclical trough conditions in Nylon Solutions, strong Plant Nutrients fundamentals amid higher input costs, and mixed Chemical Intermediates conditions with lower net pricing. The company highlighted planned plant turnarounds, record annual production across key ammonia and sulfuric acid units, additional 45Q carbon capture tax credits, final settlement proceeds related to the 2019 PES supplier shutdown claim, and conservative debt leverage. For 2026, AdvanSix expects capital expenditures of USD 75 million to USD 95 million and a pre-tax income impact from plant turnarounds of USD 20 million to USD 25 million, and announced a quarterly dividend of USD 0.16 per share payable March 23, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AdvanSix Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260219417617) on February 20, 2026, and is solely responsible for the information contained therein.